D3 PLATFORM
D3 Platform
The chemical focus of the CNPD3 is on unique natural products, and the goal is to fully exploit the biosynthetic and therapeutic potential of untapped biodiversity for drug discovery. Candidate compounds are investigated for further development through interactive chemistry and pharmacology efforts. The center embraces all aspects of natural products research from discovery, biosynthesis and chemical synthesis, assay development, screening and target identification to drug development.
CNPD3 FOCUS AND RESEARCH
CNPD3 FOCUS AND RESEARCH
Microbial Genomics & Synthetic Biology
CNPD3 FOCUS AND RESEARCH
Molecular Diversity and Screening
CNPD3 FOCUS AND RESEARCH
Molecular Pharmacology
CNPD3 FOCUS AND RESEARCH
AI-based and Structure-based Drug Design & Optimization
CNPD3 FOCUS AND RESEARCH
Synthetic Chemistry
CNPD3 Focus and Research
PROTAC & Targeted Therapeutics
CNPD3 FOCUS AND RESEARCH
Botanical Translational Science
CNPD3 FOCUS AND RESEARCH
Animal Models of Disease
A New Wave of MEDICINE
Dr. Hendrik Luesch
Answering the Call
In an ocean of possibilities, Dr. Hendrik Luesch is answering the call to make the next great drug discovery. His work takes him below the surface of the sea, where new medicines harbor hope for a healthier tomorrow.
Play Video
CNPD3 Seminar series
CNPD3 Seminar Series | Dr. Andrew Riley
Wednesday, May 17th, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Riley’s presentation is titled “From Seeds to Leads: Transforming Plant Alkaloids into Treatments for Pain and Addiction”
CNPD3 Seminar Series | Dr. Brian Hopkins
Wednesday, May 10th, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Hopkins presentation is titled “The Development of Selective Kinase Inhibitors to Treat Autoimmune Diseases”
CNPD3 Seminar Series | Dr. Matthew Thompson
Wednesday, May 3rd, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Thompson’s presentation is titled “Combating Fosfomycin Resistance in Gram-positive Pathogens”
CNPD3 Seminar Series | Dr. Gina Xiaojing Wang
Wednesday, April 12, in Communicore C1-004, 10:00 AM – 11:00 AM. Dr. Wang’s presentation is titled “Drug Discovery for Patients”
DEPARTMENT NEWS
UF College of Pharmacy researchers to develop novel treatment for stimulant use disorder
The National Institutes of Health and the National Institute on Drug Abuse awarded a $19 million grant to advance the molecule SBS-518 into a human clinical trial.
Department of medicinal chemistry celebrates banner year
The department of medicinal chemistry achieved several major milestones in the 2022-23 academic year.
UF team receives grant to study kava as smoking cessation aid
UF researchers has received a three-year $1.5 million grant from the National Center for Complementary and Integrative Health to conduct a clinical trial on the use of kava as a…
Annual award ceremony honors medicinal chemistry graduate students
The department of medicinal chemistry held its annual award ceremony to recognizes the top graduate students on Aug. 9.